Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-25 @ 7:40 PM
NCT ID:
NCT05723835
Pre Assignment Details:
A total of 47 participants with short stature either born small for gestational age(SGA), Noonan syndrome(NS), Turner syndrome(TS), or idiopathic short stature(ISS) were either treatment naïve or previously treated with growth hormone(GH) were enrolled \& exposed to once weekly dosing of somapacitan 0.24 milligrams per kilogram per week(mg/kg/week).
26-week main phase is followed by 130-week extension phase I. Study was ongoing at data cut-off date(24Nov2024).
Recruitment Details:
Participants were screened and assigned to treatment across 14 sites in 5 countries.
Study:
NCT05723835
Study Brief:
Results Section:
NCT05723835